The relationship between adherence to clinic appointments and year-one mortality for HIV infected patients at a Referral Hospital in Western Kenya

Similar documents
Factors associated with HIV infection despite overall low transmission rates in HIV Exposed Infants in rural Kenya

Ever enrolled Currently enrolled Ever on ART Sub- County Adults Peds Total Adults Peds Total Adults Peds Total Adults Peds Total

Mariza Vono Tancredi. Eliseu Alves Waldman

Differentiated Care for Antiretroviral Therapy for Key Populations: Case Examples from the LINKAGES Project

Factors associated with unsuppressed viral load in HIV-1 infected patients on 1 st line antiretroviral therapy in South Africa

DELAYS IN INITIATION OF ANTIRETROVIRAL THERAPY AMONG HIV-INFECTED CHILDREN IN RURAL ZAMBIA 9 th Interest Comference Francis H.

Monitoring of HIV positive mothers and HIV exposed infants in context of Option B+ implementation

The CIDRZ Experience: use of data to understand patient outcomes and guide program implementation 07 January 2010

Low a&ainment of virologic suppression among HIV- infected children on an;retroviral treatment 12 months a>er virologic failure in western Kenya

DREAMS: Addressing the Elevated Risk for HIV Infection among Young Women

Cohorts and Capacity Kenya

Ministry of Health. Swaziland HIV Incidence Measurement Survey (SHIMS)

CURRICULUM VITAE PERSONAL INFORMATION

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014

26 July 2017 IAS#: A

Review of the Democratic Republic of the Congo (DRC) by the Committee on the Elimination of Discrimination Against Women (CEDAW)

State of the Art for ART for Prevention. Wafaa El-Sadr, MD, MPH ICAP-Columbia University

UGANDA POPULATION-BASED HIV IMPACT ASSESSMENT UPHIA

Using Routine Health Information to Improve Voluntary Counseling and Testing in Cote d Ivoire

The Kisumu Clinical Research Site. Mumbi Makanga MBChB, MPH MTN Regional Meeting 28 th September 2016

GLOBAL AIDS MONITORING REPORT

LESOTHO POPULATION-BASED HIV IMPACT ASSESSMENT LePHIA

The Feasibility of HIV Prevention Cohort Studies among Men who have Sex with Men (MSM) in sub-saharan Africa

Developing Cervical Cancer Screening Program using HIV/ART care and treatment infrastructure. Dr. Mulindi H Mwanahamuntu

STRENGTHENING THE COORDINATION, DELIVERY AND MONITORING OF HIV AND AIDS SERVICES IN MALAWI THROUGH FAITH-BASED INSTITUTIONS.

HIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE

Cote d Ivoire Country Report FY15

International Journal of Scientific and Research Publications, Volume 6, Issue 9, September ISSN

Safe Generations Harnessing Implementation Science to Assess the Impact of Option B+ in Swaziland

Stigma and discrimination as barriers to achievement of global PMTCT and maternal health goals

The availability and cost are obstacles to using pvl in monitoring HIV treatment outcomes in resource-constrained settings

EARLY INTERVENTION SERVICES I. DEFINITION OF SERVICE

ADOLESCENTS AND HIV:

FACTORS ASSOCIATED WITH LOSS TO FOLLOW UP OF ADULT PATIENTS LIVING WITH HIV IN KIAMBU COUNTY AND REFERRAL HOSPITAL, KIAMBU COUNTY, KENYA

DETERMINANTS OF PATHWAYS TO HIV TESTING IN RURAL AND URBAN KENYA: EVIDENCE FROM THE 2008 KENYA DEMOGRAPHIC AND HEALTH SURVEY

Expansion of antiretroviral treatment to rural health. centre level by a mobile service in Mumbwa district,

HIV/AIDS CLINICAL CARE QUALITY MANAGEMENT CHART REVIEW CHARACTERISTICS OF PATIENTS FACTORS ASSOCIATED WITH IMPROVED IMMUNOLOGIC STATUS

Evaluating Retention in Medical Care and its Impact on the Health Outcomes of Individuals Living with Human Inmmunodeficiency Virus

PERFORMANCE INDICATOR REFERENCE SHEETS FOR KEY POPULATIONS

BD-PEPFAR Labs for Life Partnership

Retention in HIV care predicts subsequent retention and predicts survival well after the first year of care: a national study of US Veterans

Aidspan Review of a Study on the Costs and Health Impact of Continued Global Fund Support for Antiretroviral Therapy

ESSENTIAL PACKAGE FOR HIV CARE AND TREATMENT. Essential Package for HIV Care and Treatment

Newborn Screening for Sickle Cell Disease in Ghana Update

Accelerating Children s HIV Treatment (ACT): Rationale, Progress & Challenges

Relationship between Demographic Factors, Stage of Disease and Adherence among HIV/AIDS Patients Receiving Highly Active Antiretroviral Therapy

Substance Use Among Potential Kidney Transplant Candidates and its Impact on Access to Kidney Transplantation: A Canadian Cohort Study

Innovative Approaches for Eliminating Mother-to-Child Transmission of HIV

PMTCT (getting to zero ) Stepping up the pace and challenges of achieving emtct in low resource settings

Anti Retroviral Traitment (ARVs)

Unmet need for prevention: Analysis of condom use. Prepared by Justin Fenty

Supplementary Online Content

The Effect of Age on Immune System Reconstitution Among HIV-infected Patients on Antiretroviral Therapy in Resource Limited Settings

Improving Access to Care and ART initiation in the South: the IDP Rapid Entry Experience Jeri Sumitani, MMSc, PA-C

Suspected Renal Colic in the Emergency Department

Scaling Up Treatment in Zimbabwe: The path to high coverage

Applying Improvement to Keep HIV+ Mothers and Exposed Infants in Care. Anisa Ismail Improvement Advisor University Research Co.

No. individuals current on treatment (ART) - PEPFAR Indicator Reference Sheets

Reaching Men with Multi-Disease Testing

DIABETES SELF MANAGEMENT KNOWLEDGE AND FOOT COMPLICATIONS AMONGST TYPE 2 DIABETES PATIENTS AT JOOTRH, KISUMU COUNTY, KENYA

Supplemental Digital Content 1. Combination antiretroviral therapy regimens utilized in each study

Gender Disparities in Viral Suppression and Antiretroviral Therapy Use by Racial and Ethnic Group Medical Monitoring Project,

Conference Item (paper)

TANZANIA HIV IMPACT SURVEY (THIS)

HIV TESTING IN THE ERA OF TREATMENT SCALE UP

IPT BOTSWANA EXPERIENCE

Antiretroviral treatment outcomes after the introduction of tenofovir in the public-sector in South Africa

Implementing revised TB/HIV recording and reporting tools Country Experience. Dr Nathan Kapata National TB/ Leprosy Programme Manager

Chiang Mai University/Johns Hopkins University HIV/AIDS Research on VCT

Delay in the Provision of Antiretroviral Therapy to HIV-infected TB Patients in Nigeria

Determinants of provider-initiated HIV testing and counselling uptake at Jaramogi Oginga Odinga Teaching and Referral Hospital, Kisumu, Kenya

Patient Involvement in Pharmacovigilance: The Development of an HIV Peer Educator Program

SURVIVAL PROBABILITIES OF PAEDIATRIC PATIENTS REGISTERED IN ART CENTRE AT NEW CIVIL HOSPITAL, SURAT

WHO HIV Drug Resistance Strategy

Bukoba Combination Prevention Evaluation: Effective Approaches to Linking People Living with HIV to Care and Treatment Services in Tanzania

Objective: Specific Aims:

Predictors of drug sensitive tuberculosis treatment outcomes among hospitalised

World Food Programme (WFP)

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs

SESSION VI: Forecasting, estimating requirements for Procurement of HIV related supplies

Service Model: For Non-Clinical and Clinical Settings: HIV Testing. Agencies may employ evidence-based strategies, including the social network

GENERAL PROFILE AND SURVIVAL PROBABILITIES OF HIV PATIENTS REGISTERED AT ANTI RETROVIRAL THERAPY CENTRE, NEW CIVIL HOSPITAL, SURAT, GUJARAT

targets for HIV-positive children

WHO HIV Drug Resistance Prevention and Assessment Strategy. Dr Richard Banda Technical Officer, HIV Drug Resistance WHO Inter-country Support Team

The ENRICH Study Evaluating an Innovative Approach to Increasing Use of Isoniazid Preventive Therapy to Prevent TB among People Living with HIV

Dr. Pascal Nji Atanga MD, MPH, PhD(c) University of Buea/Center for International Health, Ludwig Maximillians University Muenchen, Germany

The University of Mississippi School of Pharmacy

Management of Antiretroviral Treatment (ART) and Long-Term Adherence to ART

Title: Meta-analysis of Individual patient Data (IPD) of Patients with INH (mono or poly-drug) Resistant Tuberculosis.

Beyond the Prison Walls: Relinkage and Retention 2.0

Progress in scaling up HIV prevention and treatment in sub-saharan Africa: 15 years, the state of AIDS

Reducing Malnutrition in Zambia: Summary of Estimates to Support Nutrition Advocacy ZAMBIA NUTRITION PROFILES 2017

Malawi s Option B+ Key Considerations & Progress

No Disclosures. The University of Michigan Rotator Cuff Registry: Lessons we have learned WHY I CHOSE TO STUDY ROTATOR CUFF DISEASE

Measuring Impact PHIA Findings from Malawi, Zimbabwe, and Zambia

This evaluation was funded by the Centers for Disease Control and Prevention

The Global Partnership for HIV-Free Survival (PHFS): Quality Improvement and Breastfeeding / ART compliance

All four components must be present, but Part A funds to be used for HIV testing only as necessary to supplement, not supplant, existing funding.

Positive Health, Dignity, and Prevention (PHDP) Webinar Series: Five Ways to Accelerate Progress Toward the Goals

Pharmacovigilance of highly active antiretroviral therapy among adult patients in a large urban HIV treatment center in Nigeria

Transcription:

The relationship between adherence to clinic appointments and year-one mortality for HIV infected patients at a Referral Hospital in Western Kenya Muthusi, K; Burmen, B 8th International Workshop on HIV Treatment, Pathogenesis and Prevention Research in Resource- Limited Settings INTEREST 5-9 May 2014, Lusaka, Zambia

HIV Epidemiology Kenya Population 38.6 million 1 HIV Prevalence among persons aged 15-49 years 5.1% 2 51% know their HIV status 2 46% in HIV care 2 43% retained in care after 1 year 2 Population 5.4million 1 HIV prevalence among persons aged 15-49 years 15.2% 2 1 Kenya National Bureau of Statistics K. Population and Housing Census. 2011 [cited 2013 April 1st ]; Available from: http://www.knbs.or.ke/population.php 2 National AIDS and STI Control Program N. Kenya AIDS Indicator Survey 2012: Preliminary Report. Nairobi, Kenya: Ministry of Health, Kenya; 2013 September

Effect of non-adherence to clinic appointment on treatment outcomes of HIV infected patients Previous studies have shown that appointment adherence is necessary for monitoring of disease progression 3,4 appropriate timing of ART initiation 5 adherence to Anti-Retroviral Therapy (ART) 6 recognition of failure 5 prevention of drug resistance 5 Adherence to clinic appointments can therefore be used as an objective proxy for self-reported adherence to treatment 7 3 Fong R, et al Factors associated with virological failure in a cohort of combination antiretroviral therapy-treated patients managed at a tertiary referral centre. Sex Health. 2013 Nov; 10(5):442-7. 4 Peterson K, et al. Use of Self-Reported Adherence and Keeping Clinic Appointments as Predictors of Viremia in Routine HIV Care in the Gambia. J Int Assoc Provid AIDS Care 2013 Aug 30 5 National AIDS and STI Control Program N. Guidelines for Antiretroviral therapy in Kenya 4th Edition. Nairobi, National AIDS and STI Control Program; 2011. 6 Israelski D, et al Sociodemographic characteristics associated with medical appointment adherence among HIV-seropositive patients seeking treatment in a county outpatient facility. Prev Med. 2001 Nov; 33(5):470-5. 7 World Health Organization WHO. RETENTION IN HIV PROGRAMMES Defining the challenges and identifying solutions. Geneva; 2011 13th-15th September.

Objective To examine the relationship between adherence to outpatient HIV clinic appointments and year-one mortality rates for newly enrolled HIV-infected patients at the JOOTRH HIV clinic Hospital is largest public health facility in Nyanza Referral in western Kenya

Methods Retrospective review of the electronic medical records for newly enrolled patients at the JOOTRH HIV clinic between Jan 2011 and Dec 2012 Patients aged 15 years Risk factors include: Demographic: Age, gender, education, Clinical: CD4, WHO stage, ART eligibility Psycho-social: Support group, disclosure Analytic methods Alternating Logistic Regression Cox proportional hazards

Adherence to medical appointments Outcomes Adherent patients (Nondefaulters); attended all clinic appointments as scheduled or within 3 days of the scheduled date Non-adherent patients (Defaulters); did not attend clinic appointments as scheduled Measured at each scheduled appointment Patient outcomes at end alive, transferred, dead or lost to follow-up

Selected characteristics of newly infected HIV patients at JOOTRH, 2011-2012 582 new HIV patients enrolled 89% (n=516) aged 24 years 60% (n=347) female 92% (n=538) had primary or lower education 88% (n=510) had disclosed their HIV status 82% (n=477) ART-eligible at enrolment by clinical & immunological staging. ALL initiated on ART 44% (n=258) were defaulters 3%(n=19) died

Comparisons of selected patient characteristics between defaulter and non-defaulters Characteristic Defaulters Non-defaulters 258 (44%) 324 (56%) P-value Age group 15-24 years 32(12) 34(10) 0.47 24 years 226(88) 290(90) Gender Male 107(41) 128(40) 0.63 Female 151(59) 196(60) Education level Above primary 28(11) 16(5) 0.01 Primary or less 230(89) 308(95) Smoking Yes 16(6) 8(2) 0.02 No 242(94) 316(98) Disclosed to who Both family & non-family 120 (53) 168 (60) 0.03 Family 37 (16) 57 (20) Non-family 11 (5) 15 (5) Not specified 59 (26) 43 (15)

Odds ratios for selected risk factors associated with rate of defaulting clinic appointments over Characteristic Unadjusted OR (95% CI) p-value Adjusted OR (95% CI) Age group 15-24 years 1.3 (0.9-2.0) 0.13 - - >= 24 years ref ref Gender Female 1.0 (0.8-1.3) 0.98 - - Male ref ref p-value Employed No 1.3 (1.0-1.7) 0.03 1.4 (1.1-1.9) 0.014 Yes ref ref Smokers Yes 1.9 (1.1-3.4) 0.02 2.2 (1.3-3.8) 0.003 Disclosed to who No ref ref Both family and non-family ref ref Family 1.4 (0.9-2.0) 0.08 1.4 (0.9-2.1) 0.072 Non family 1.5 (0.8-3.0) 0.24 1.5 (0.7-3.1) 0.335 Not specified 1.9 (1.4-2.6) <.0001 2.2 (1.4-3.3) 0.0003

Impact of adherence to clinic appointments on year-one mortality rates among HIV patients enrolled at JOOTHR Adherence to clinic visits for 1 year Patients (N=582) Deaths n=19 (%) Total follow up time (person years) Death rate per 100 person years Hazard ratio (95% CI) Adherence status Defaulters 258 12(63) 99.3 4.0 3.2 (1.2-8.0) Non-defaulters 324 7(37) 222.5 3.1 ref Cumulative elapsed time from appointment to actual visit (days) None 324 7 (37) 222.5 3.2 ref 4-60 days 187 7 (37) 69.9 10.0 4.1 (1.4-11.8) 60+ days 71 5 (26) 29.3 17.1 5.0 (1.5-17.0)

Limitations Inability to determine true outcomes of lost to follow-up patients Inability to control for other factors associated with mortality TB co-infection Recurrent illnesses during the follow-up period A short follow up period of one year

Conclusion High rate of non adherence to clinic appointments associated with risk of death Patients likely to default had not disclosed their HIV status, were unemployment or smokers. Non-adherence to clinic appointments is linked to poor patient outcomes Risk of death increases with increase in cumulative days elapsed between scheduled appointment and actual visit

Recommendations Institute interventions to improve adherence targeting e.g., Patient not yet disclosed their HIV status, unemployed and smokers Patient involvement in scheduling & rescheduling of appointments in the event of unexpected circumstances Further analysis to address other causes of mortality Assess treatment adherence using other means

Acknowledgement HIV INFECTED PATIENTS AT JOOTRH JOOTRH KEMRI KEMRI-CGHR CDC KENYA MOH NASCOP 8 TH INTEREST WORKSHOP

THANK YOU This project was made possible by support from the President's Emergency Plan for AIDS Relief (PEPFAR) through a cooperative agreement Grant Number 5419GH000041 from the U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV/AIDS (DGHA). For more information please contact: KEMRI/CDC P.O. Box 1578 Kisumu, Kenya E-mail: info@ke.cdc.gov 254.572.022.929 254.720.374.226 254.734.512.232 The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.